Related Experiment Videos

Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based

Scott A McDonald1, Sharon J Hutchinson, Sheila M Bird

  • 1Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK. smcdonald4@nhs.net

European Journal of Gastroenterology & Hepatology
|September 24, 2009
PubMed

Insights

Hepatitis C virus (HCV) infection leads to increasing decompensated cirrhosis cases, particularly in older men and those with HIV or alcohol use. Addressing alcohol consumption is crucial for managing HCV complications.

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • Chronic hepatitis C virus (HCV) infection can progress to cirrhosis and its complications.
  • Limited data exist on the progression to decompensated cirrhosis in diverse populations.
  • Understanding the healthcare burden of HCV-related decompensated cirrhosis is essential.

Purpose of the Study:

  • To characterize the national healthcare burden of HCV-related decompensated cirrhosis in Scotland.
  • To estimate associations between epidemiological variables and the risk of decompensated cirrhosis or death.

Main Methods:

  • A record-linkage study of 20,969 individuals diagnosed with HCV between 1991 and 2006.
  • Linking laboratory diagnoses with hospital discharge data and national HIV databases.
  • Analyzing time to first hospital admission or death with mention of decompensated cirrhosis.

Main Results:

  • 995 individuals were hospitalized, and 63 died with first-time mention of decompensated cirrhosis.
  • New cases of decompensated cirrhosis increased annually by 11% (1996-2005).
  • Higher risks were observed in men, HIV coinfection, prior alcohol-related admissions, and older age groups.

Conclusions:

  • The burden of HCV-related decompensated cirrhosis is rising due to an aging population.
  • Synergistic effects of HCV and alcohol accelerate liver disease progression.
  • Policy-makers must consider alcohol intake in HCV management resource allocation.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...